Search Results

COVID-19 Serum Drives Spike-Mediated SARS-CoV-2 Variation.

• Authors : Yu, Yuanling¹ (AUTHOR) ; Zhang, Mengyi^2,3 (AUTHOR) ; Huang, Lan¹ (AUTHOR)

• Source: Viruses (1999-4915). May2024, Vol. 16 Issue 5, p763. 10p.

Record details

Intra-Host Evolution Analyses in an Immunosuppressed Patient Supports SARS-CoV-2 Viral Reservoir Hypothesis.

• Authors : Fournelle, Dominique^1,2 (AUTHOR) ; Mostefai, Fatima^1,2 (AUTHOR) ; Brunet-Ratnasingham, Elsa^3,4 (AUTHOR)

Subjects: *IMMUNOCOMPROMISED patients; *SARS-CoV-2; *CONVALESCENT plasma

• Source: Viruses (1999-4915). Mar024, Vol. 16 Issue 3, p342. 13p.

Record details

Prolonged SARS-CoV-2 Infection in Patients Receiving Anti-CD20 Monoclonal Antibodies: A Diagnostic Challenged by Negative Nasopharyngeal RT-PCR and Successful Treatment with COVID-19 High-Titer Convalescent Plasma.

• Authors : Da Silva, Léa¹ (AUTHOR) ; Klopfenstein, Timothée¹ (AUTHOR) ; Gendrin, Vincent¹ (AUTHOR)

Subjects: *CONVALESCENT plasma; *COVID-19 treatment; *SARS-CoV-2

• Source: Viruses (1999-4915). Nov2023, Vol. 15 Issue 11, p2220. 8p.

Record details

Correlation between Clinical Characteristics and Antibody Levels in COVID-19 Convalescent Plasma Donor Candidates.

• Authors : Uzun, Günalp^1,2 (AUTHOR) ; Müller, Rebecca³ (AUTHOR) ; Althaus, Karina^1,2 (AUTHOR)

Subjects: *CONVALESCENT plasma; *IMMUNOGLOBULINS; *FEVER

• Source: Viruses (1999-4915). Jun2023, Vol. 15 Issue 6, p1357. 12p.

Record details

Convalescent Plasma Therapy for COVID-19: A Systematic Review and Meta-Analysis on Randomized Controlled Trials.

• Authors : Filippatos, Charalampos¹ (AUTHOR); Ntanasis-Stathopoulos, Ioannis¹ (AUTHOR); Sekeri, Kalliopi¹ (AUTHOR)

Subjects: *CONVALESCENT plasma; *COVID-19 treatment; *RANDOMIZED controlled trialsEUROPE

• Source: Viruses (1999-4915). Mar2023, Vol. 15 Issue 3, p765. 19p.

Record details

Convalescent Plasma Treatment of Patients Previously Treated with B-Cell-Depleting Monoclonal Antibodies Suffering COVID-19 Is Associated with Reduced Re-Admission Rates.

• Authors : Ioannou, Petros^1,2 (AUTHOR) ; Katsigiannis, Athanasios² (AUTHOR); Papakitsou, Ioanna² (AUTHOR)

Subjects: *CONVALESCENT plasma; *RITUXIMAB; *MONOCLONAL antibodiesGREECE

• Source: Viruses (1999-4915). Mar2023, Vol. 15 Issue 3, p756. 12p.

Record details

Early Treatment with Monoclonal Antibodies or Convalescent Plasma Reduces Mortality in Non-Vaccinated COVID-19 High-Risk Patients.

• Authors : Thümmler, Laura^1,2 (AUTHOR); Lindemann, Monika² (AUTHOR); Horn, Peter A.² (AUTHOR)

Subjects: *CONVALESCENT plasma; *MONOCLONAL antibodies; *COVID-19

• Source: Viruses (1999-4915). Jan2023, Vol. 15 Issue 1, p119. 10p.

Record details

Cross-Reactivity of SARS-CoV-2 Nucleocapsid-Binding Antibodies and Its Implication for COVID-19 Serology Tests.

• Authors : Rak, Alexandra¹ (AUTHOR); Donina, Svetlana¹ (AUTHOR); Zabrodskaya, Yana^1,2,3 (AUTHOR)

Subjects: *SARS-CoV-2; *CONVALESCENT plasma; *COVID-19

• Source: Viruses (1999-4915). Sep2022, Vol. 14 Issue 9, p2041-N.PAG. 11p.

Record details

Validation of Viral Inactivation Protocols for Therapeutic Blood Products against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2).

• Authors : Belem, Wendimi Fatimata¹ (AUTHOR); Liu, Ching-Hsuan² (AUTHOR); Hu, Yee-Tung³ (AUTHOR)

Subjects: *SARS-CoV-2; *BLOOD products; *MONOCLONAL antibodies

• Source: Viruses (1999-4915). Nov2022, Vol. 14 Issue 11, p2419. 14p.

Record details

On the Need to Determine the Contribution of Anti-Nucleocapsid Antibodies as Potential Contributors to COVID-19 Convalescent Plasma Efficacy.

• Authors : Focosi, Daniele¹ (AUTHOR) ; Franchini, Massimo² (AUTHOR); Casadevall, Arturo³ (AUTHOR)

Subjects: *CONVALESCENT plasma; *IMMUNOGLOBULINS; *VIRAL antibodies

• Source: Viruses (1999-4915). Nov2022, Vol. 14 Issue 11, p2378. 6p.

Record details